Influence of physicians' seniority on efficacy of silver needle therapy for low back fasciitis: A prospective, cohort study

Medicine (Baltimore). 2023 May 26;102(21):e33862. doi: 10.1097/MD.0000000000033862.

Abstract

Background: Physicians' seniority has always been the focus of patients. Silver needle therapy (SNT) has been applied for more than 60 years. It is similar to moxibustion and has a good therapeutic effect on soft tissue pain. This study aimed to determine the influence of physicians' seniority on the efficacy of SNT for patients with low back fasciitis.

Methods: This was a prospective cohort study at the Affiliated Hospital of Qingdao University. Patients diagnosed with low back fasciitis were split into junior physician (JP) and senior physician (SP) groups (n = 30) based on the seniority of the physician. The numerical rating scale (NRS) was administered during the SNT, and operation time was recorded. The NRS, Oswestry Disability Index (ODI), and Short-Form 12 of quality of life (SF-12) scores at 1, 2, 6, and 12 months after the treatment and autonomic nervous system (ANS) activity were also observed.

Results: Compared with the SP group, the NRS score during the SNT (5.20 ± 0.71 vs 2.53 ± 0.94) and operation time (11.7 ± 1.6 minutes vs 6.8 ± 1.1 minute) were higher in the JP group (P < .05). The NRS, ODI score, SF-12 score, and ANS activity after treatment were not significantly different between SP and JP groups. Additionally, in the multivariate linear regression analysis model, the physicians' seniority was an independent factor affecting the NRS score during the SNT and operation time (P < .05).

Conclusion: SNT could attenuate the pain of patients with low back fasciitis in the short and long term without severe complications. The physicians' seniority did not influence the efficacy of SNT, but the JP group showed an increased operation time and a higher degree of pain during the operation.

MeSH terms

  • Cohort Studies
  • Humans
  • Lumbar Vertebrae / surgery
  • Pain
  • Prospective Studies
  • Quality of Life*
  • Silver*
  • Treatment Outcome

Substances

  • Silver